Results
432
Companies with a Value score of at least 3, ordered by Value score
432 companies
Spectrum Pharmaceuticals
Market Cap: €209.9m
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.
NTR
€0.93
7D
0.5%
1Y
11.6%
Royalty Pharma
Market Cap: €20.7b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPD
€29.78
7D
-3.3%
1Y
19.1%
Teva Pharmaceutical Industries
Market Cap: €21.4b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEV
€15.30
7D
-9.5%
1Y
-3.5%
Perrigo
Market Cap: €2.9b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PIG
€17.87
7D
-5.3%
1Y
-28.7%
Sanofi
Market Cap: €96.7b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SNW
€79.80
7D
-1.2%
1Y
-22.5%
Hikma Pharmaceuticals
Market Cap: €3.6b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
H5P
€18.70
7D
-4.1%
1Y
-17.3%
Regeneron Pharmaceuticals
Market Cap: €59.6b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
RGO
€481.50
7D
1.7%
1Y
-53.1%
Grand Pharmaceutical Group
Market Cap: €30.9b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
MX6A
€0.93
7D
-5.6%
1Y
98.7%
Merck
Market Cap: €202.5b
Operates as a healthcare company worldwide.
6MK
€68.40
7D
-4.2%
1Y
-35.6%
Genomma Lab Internacional. de
Market Cap: €19.9b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
GEKA
€0.91
7D
-5.2%
1Y
-5.7%
Sanofi
Market Cap: €96.7b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SNW
€79.52
7D
-1.0%
1Y
-22.8%
Evolus
Market Cap: €421.7m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EVL
€5.45
7D
-12.8%
1Y
-62.7%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Market Cap: €1.8t
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
RIG2
€25.12
7D
-2.9%
1Y
-8.9%
Amphastar Pharmaceuticals
Market Cap: €1.3b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
29A
€22.27
7D
-9.2%
1Y
-48.6%
CorMedix
Market Cap: €904.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
19KA
€9.55
7D
-14.0%
1Y
50.4%
Kalbe Farma
Market Cap: €54.0t
Develops, manufactures, and trades in pharmaceutical products in Indonesia.
LCLA
€0.066
7D
28.2%
1Y
n/a
Merck
Market Cap: €202.5b
Operates as a healthcare company worldwide.
6MK
€69.40
7D
-3.1%
1Y
-34.9%
Goodbody Health
Market Cap: €1.3m
Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.
A3DTP0
€0.085
7D
0%
1Y
-83.0%
Otsuka Holdings
Market Cap: €4.3t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
OS1
€46.60
7D
-1.7%
1Y
-5.7%
Novo Nordisk
Market Cap: €1.6t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOV
€49.77
7D
6.5%
1Y
-58.0%
Novartis
Market Cap: €187.0b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOT0
€13.60
7D
-5.6%
1Y
n/a
Viatris
Market Cap: €11.1b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VIA
€8.21
7D
-6.3%
1Y
-22.1%
Amneal Pharmaceuticals
Market Cap: €3.1b
A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.
2DT
€8.10
7D
-2.4%
1Y
8.7%
Viatris
Market Cap: €11.1b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VIA
€8.22
7D
-6.4%
1Y
-22.9%
Fortrea Holdings
Market Cap: €913.4m
A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
K67
€8.25
7D
1.2%
1Y
-57.7%
Aspen Pharmacare Holdings
Market Cap: €43.9b
Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.
LDZA
€4.80
7D
-4.0%
1Y
-50.3%
Merck KGaA
Market Cap: €46.8b
Operates as a science and technology company in Germany.
MRKC
€20.80
7D
-3.7%
1Y
-36.6%
Merck
Market Cap: €202.5b
Operates as a healthcare company worldwide.
6MK0
€11.00
7D
-5.2%
1Y
n/a
Bayer
Market Cap: €26.9b
Operates as a life science company worldwide.
BAYN
€27.45
7D
-2.0%
1Y
-1.5%
Beximco Pharmaceuticals
Market Cap: €54.5b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
R2WA
€0.40
7D
0%
1Y
63.9%
Prestige Consumer Healthcare
Market Cap: €3.1b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBV
€53.00
7D
-3.6%
1Y
-19.1%
Delivra Health Brands
Market Cap: €5.9m
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
3F0
€0.11
7D
2.8%
1Y
6.7%
Newron Pharmaceuticals
Market Cap: €192.4m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NP5
€9.98
7D
6.9%
1Y
16.2%
Regeneron Pharmaceuticals
Market Cap: €59.6b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
RGO
€494.70
7D
4.2%
1Y
n/a
CureVac
Market Cap: €1.2b
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
5CV
€4.49
7D
-0.9%
1Y
53.4%
OSE Immunotherapeutics
Market Cap: €127.7m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
6OP
€5.83
7D
-4.0%
1Y
-18.8%